USP Human Growth Hormone Monographs Issued; Generics Status Unresolved
Executive Summary
U.S. Pharmacopeia's release of monographs on human growth hormone appears unlikely to significantly advance the debate over an abbreviated pathway for HGH follow-on products
You may also be interested in...
Generic Biologics Legislation Unlikely, But Issue Not Going Away
The push for legislation creating a follow-on biologics pathway is "cooling off," Senate Aging Committee majority counsel Steve Irizarry told the Stanford Washington Research Group conference in Washington, D.C. May 5
Generic Biologics Legislation Unlikely, But Issue Not Going Away
The push for legislation creating a follow-on biologics pathway is "cooling off," Senate Aging Committee majority counsel Steve Irizarry told the Stanford Washington Research Group conference in Washington, D.C. May 5
Ista Tries To Void Vitrase NME Status: Will Less Exclusivity Mean More?
Ista is requesting its hyaluronidase product Vitrase be downgraded from new molecular entity status in order to obtain more meaningful exclusivity